G. Smith

The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668.

D. Janus, K. Menear, David J. Farr, 1998, Bioorganic & medicinal chemistry letters.

Studies towards the identification of potent, selective and bioavailable thrombin inhibitors.

D. Janus, K. Menear, D. Bentley, 1999, Bioorganic & medicinal chemistry letters.

The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.

D. Brundish, D. Janus, X. Cockcroft, 2000, Bioorganic & medicinal chemistry letters.

Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potency.

M. McDonnell, R. Wakeford, D. Brundish, 1999, Journal of Medicinal Chemistry.

Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease.

D. S. Williamson, G. Smith, G. Smith, 2017, Progress in medicinal chemistry.

Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60G.

M. Grütter, J. Priestle, B. Wathey, 1999, Bioorganic & Medicinal Chemistry Letters.